
Join to View Full Profile
55 Fruit St# WRN825Boston, MA 02114
Phone+1 617-726-5209
Fax+1 617-643-1624
Dr. Duncan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 1990 - 1991
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1990
- Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1991 - 2026
- MO State Medical License 1990 - 2026
- NY State Medical License 2012 - 2026
- VT State Medical License 2013 - 2026
- ME State Medical License 2016 - 2025
- GA State Medical License 2013 - 2021
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5.Lyn M Duncan, David E Elder, Michael W Piepkorn, Stevan R Knezevich, Willeke A M Blokx
Journal of Cutaneous Pathology. 2025-04-04 - Martin C. Mihm, Jr. and Dermatopathology Education at Harvard Medical School.Lyn M Duncan, Steven R Tahan, Mai P Hoang, George F Murphy
Journal of Cutaneous Pathology. 2025-01-07 - 2 citationsSinonasal Mucosal Melanoma: A Contemporary Review.Ruth K Foreman, Lyn M Duncan
Surgical Pathology Clinics. 2024-12-01
Lectures
- Dermatopathology UpdateHarvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/19/2013
- Dermatopathology Update With Mini-Symposiums on Inflammatory Dermatoses and New Diagnostic Testings for Melanocytic LesionsHarvard Medical School, Boston, Massachusetts - 9/20/2012
Press Mentions
- Loss of GCNT2/I-branched Glycans Enhances Melanoma Growth and SurvivalAugust 22nd, 2018
Professional Memberships
- Fellow
- Fellow
- American Society of DermatopathologyPresident
- International Society of DermatopathologyMember
- International Melanoma Study GroupMember
- Society for Melanoma ResearchMember
- United States Cutaneous Lymphoma ConsortiumMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: